glp 1 new drug Professor Receives Grant to Study Effectiveness of GLP-1 Weight-Loss Drugs Ozempic, Wegovy: Why GLP-1 Drugs

Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction

After asking whether Medicare should cover the cost of GLP-1s when prescribed for weight loss for people who are overweight, the poll presented two different arguments for and against this proposal: Argument against: Some people say that if Medicare covers the cost of these drugs, it could increase premiums paid by people with Medicare and place financial pressure on the Medicare program and the federal budget

It further reveals how current advances in triple agonists and oral formulations promise to further lower barriers to treatment and enhance therapeutic outcomes

And, although pulmonary aspiration is a rare complication in patients undergoing anesthetic care, it is devastating

A recent study indicated a consistent increase in prescriptions for obesity management medications in the United States, rising from 0.76 to 0.80 million between July 2017 and June 2018 and from 1.29 to 1.51 million between March 2023 and February 2024